Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Involvement of interferon-tau in the induction of apoptotic, pyroptotic, and autophagic cell death-related signaling pathways in the bovine uterine endometrium during early pregnancy.

Suzuki T, Sakumoto R, Hayashi KG, Ogiso T, Kunii H, Shirozu T, Kim SW, Bai H, Kawahara M, Kimura K, Takahashi M.

J Reprod Dev. 2018 Oct 8. doi: 10.1262/jrd.2018-063. [Epub ahead of print]

2.

Takayasu arteritis detected by PET/MRI with 18F-fluorodeoxyglucose.

Takeishi Y, Kiko T, Yokokawa T, Kunii H, Ichimura S, Takizawa S, Masuda A, Kaneshiro T, Ando T, Takenoshita S.

J Nucl Cardiol. 2018 Sep 20. doi: 10.1007/s12350-018-1431-4. [Epub ahead of print] No abstract available.

PMID:
30238297
3.

Feasibility of skin acetone analysis in patients with cardiovascular diseases.

Yokokawa T, Sato T, Suzuki S, Oikawa M, Yoshihisa A, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Ishida T, Takeishi Y.

Fukushima J Med Sci. 2018 Aug 29;64(2):60-63. doi: 10.5387/fms.2018-03. Epub 2018 Jul 14.

4.

Hot topic: Pregnancy-induced expression of interferon-stimulated genes in the cervical and vaginal mucosal membranes.

Kunii H, Koyama K, Ito T, Suzuki T, Balboula AZ, Shirozu T, Bai H, Nagano M, Kawahara M, Takahashi M.

J Dairy Sci. 2018 Sep;101(9):8396-8400. doi: 10.3168/jds.2017-14251. Epub 2018 Jun 21.

PMID:
29935833
5.

Change of Exhaled Acetone Concentration Levels in Patients with Acute Decompensated Heart Failure.

Yokokawa T, Sato T, Suzuki S, Oikawa M, Yoshihisa A, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Ishida T, Shimouchi A, Takeishi Y.

Int Heart J. 2018 Jul 31;59(4):808-812. doi: 10.1536/ihj.17-482. Epub 2018 May 23.

6.

Activation of lysosomal cathepsins in pregnant bovine leukocytes.

Talukder MAS, Balboula AZ, Shirozu T, Kim SW, Kunii H, Suzuki T, Ito T, Kimura K, Takahashi M.

Reproduction. 2018 Jun;155(6):515-528. doi: 10.1530/REP-18-0078. Epub 2018 Apr 6.

PMID:
29626104
7.

Relation of Testosterone Levels to Mortality in Men With Heart Failure.

Yoshihisa A, Suzuki S, Sato Y, Kanno Y, Abe S, Miyata M, Sato T, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Ishida T, Takeishi Y.

Am J Cardiol. 2018 Jun 1;121(11):1321-1327. doi: 10.1016/j.amjcard.2018.01.052. Epub 2018 Mar 1.

8.

Usefulness of Urinary N-Terminal Fragment of Titin to Predict Mortality in Dilated Cardiomyopathy.

Yoshihisa A, Kimishima Y, Kiko T, Sato Y, Watanabe S, Kanno Y, Abe S, Miyata M, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Ishida T, Takeishi Y.

Am J Cardiol. 2018 May 15;121(10):1260-1265. doi: 10.1016/j.amjcard.2018.01.046. Epub 2018 Feb 12.

9.

Association of Serum Zinc Level With Prognosis in Patients With Heart Failure.

Yoshihisa A, Abe S, Kiko T, Kimishima Y, Sato Y, Watanabe S, Kanno Y, Miyata-Tatsumi M, Misaka T, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Ishida T, Takeishi Y.

J Card Fail. 2018 Jun;24(6):375-383. doi: 10.1016/j.cardfail.2018.02.011. Epub 2018 Mar 2.

10.

Association between sleep-disordered breathing and arterial stiffness in heart failure patients with reduced or preserved ejection fraction.

Suzuki S, Yoshihisa A, Sato Y, Watanabe S, Yokokawa T, Sato T, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Ishida T, Takeishi Y.

ESC Heart Fail. 2018 Jun;5(3):284-291. doi: 10.1002/ehf2.12273. Epub 2018 Feb 20.

11.

Liver fibrosis marker, 7S domain of collagen type IV, in patients with pre-capillary pulmonary hypertension.

Yoshihisa A, Kimishima Y, Kiko T, Sato Y, Watanabe S, Kanno Y, Abe S, Miyata-Tatsumi M, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Ishida T, Takeishi Y.

Int J Cardiol. 2018 May 1;258:269-274. doi: 10.1016/j.ijcard.2018.01.138. Epub 2018 Feb 8.

PMID:
29428236
12.

Impact of nutritional indices on mortality in patients with heart failure.

Yoshihisa A, Kanno Y, Watanabe S, Yokokawa T, Abe S, Miyata M, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Suzuki H, Ishida T, Takeishi Y.

Open Heart. 2018 Jan 9;5(1):e000730. doi: 10.1136/openhrt-2017-000730. eCollection 2018.

13.

Subclinical Hypothyroidism Is Associated With Adverse Prognosis in Heart Failure Patients.

Sato Y, Yoshihisa A, Kimishima Y, Kiko T, Watanabe S, Kanno Y, Abe S, Miyata M, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Ishida T, Takeishi Y.

Can J Cardiol. 2018 Jan;34(1):80-87. doi: 10.1016/j.cjca.2017.10.021. Epub 2017 Nov 8.

14.

Elevated exhaled acetone concentration in stage C heart failure patients with diabetes mellitus.

Yokokawa T, Sato T, Suzuki S, Oikawa M, Yoshihisa A, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Ishida T, Shimouchi A, Takeishi Y.

BMC Cardiovasc Disord. 2017 Nov 16;17(1):280. doi: 10.1186/s12872-017-0713-0.

15.

Cardiopulmonary exercise testing as prognostic indicators: Comparisons among heart failure patients with reduced, mid-range and preserved ejection fraction.

Sato T, Yoshihisa A, Kanno Y, Suzuki S, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Ishida T, Takeishi Y.

Eur J Prev Cardiol. 2017 Dec;24(18):1979-1987. doi: 10.1177/2047487317739079. Epub 2017 Oct 31.

PMID:
29086584
16.

Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction.

Yoshihisa A, Sato Y, Yokokawa T, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Saitoh SI, Takeishi Y.

ESC Heart Fail. 2018 Apr;5(2):262-270. doi: 10.1002/ehf2.12222. Epub 2017 Oct 2.

17.

A massive tsunami promoted gene flow and increased genetic diversity in a near threatened plant species.

Ohbayashi K, Hodoki Y, I Kondo N, Kunii H, Shimada M.

Sci Rep. 2017 Sep 7;7(1):10933. doi: 10.1038/s41598-017-11270-5.

18.

The CHA2 DS2 -VASc score as a predictor of high mortality in hospitalized heart failure patients.

Yoshihisa A, Watanabe S, Kanno Y, Takiguchi M, Sato A, Yokokawa T, Miura S, Shimizu T, Abe S, Sato T, Suzuki S, Oikawa M, Sakamoto N, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Takeishi Y.

ESC Heart Fail. 2016 Dec;3(4):261-269. doi: 10.1002/ehf2.12098. Epub 2016 Jul 18.

PMID:
28834660
19.

Successful revascularization of advanced coronary artery disease associated with pseudoxanthoma elasticum.

Anzai F, Kunii H, Kanno Y, Kamioka M, Kobayashi A, Suzuki H, Saitoh S, Takeishi Y.

J Cardiol Cases. 2017 Jul 27;16(4):101-104. doi: 10.1016/j.jccase.2017.05.001. eCollection 2017 Oct.

20.

Pulmonary Artery Diameter Predicts Lung Injury After Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension.

Sugimoto K, Nakazato K, Sakamoto N, Yamaki T, Kunii H, Yoshihisa A, Suzuki H, Saitoh SI, Takeishi Y.

Int Heart J. 2017 Aug 3;58(4):584-588. doi: 10.1536/ihj.16-365. Epub 2017 Jul 13.

21.

Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure.

Sato Y, Yoshihisa A, Kanno Y, Watanabe S, Yokokawa T, Abe S, Misaka T, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Saitoh SI, Takeishi Y.

Open Heart. 2017 Apr 28;4(1):e000598. doi: 10.1136/openhrt-2017-000598. eCollection 2017.

22.

Clinical features of extremely elderly patients with heart failure.

Yokokawa T, Yoshihisa A, Kanno Y, Sato T, Suzuki S, Misaka T, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Takeishi Y.

Geriatr Gerontol Int. 2017 Nov;17(11):2194-2199. doi: 10.1111/ggi.13060. Epub 2017 May 21.

PMID:
28544166
23.

Associations of Acid Suppressive Therapy With Cardiac Mortality in Heart Failure Patients.

Yoshihisa A, Takiguchi M, Kanno Y, Sato A, Yokokawa T, Miura S, Abe S, Misaka T, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Takeishi Y.

J Am Heart Assoc. 2017 May 16;6(5). pii: e005110. doi: 10.1161/JAHA.116.005110.

24.

Plasma volume status predicts prognosis in patients with acute heart failure syndromes.

Yoshihisa A, Abe S, Sato Y, Watanabe S, Yokokawa T, Miura S, Misaka T, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Saitoh SI, Takeishi Y.

Eur Heart J Acute Cardiovasc Care. 2018 Jun;7(4):330-338. doi: 10.1177/2048872617690889. Epub 2017 Jan 31.

PMID:
28139135
25.

Pulmonary Arterial Capacitance Predicts Cardiac Events in Pulmonary Hypertension Due to Left Heart Disease.

Sugimoto K, Yoshihisa A, Nakazato K, Jin Y, Suzuki S, Yokokawa T, Misaka T, Yamaki T, Kunii H, Suzuki H, Saitoh SI, Takeishi Y.

PLoS One. 2016 Nov 22;11(11):e0165603. doi: 10.1371/journal.pone.0165603. eCollection 2016.

26.

The CHA2DS2-VASc score as a predictor of high mortality in hospitalized heart failure patients.

Yoshihisa A, Watanabe S, Kanno Y, Takiguchi M, Sato A, Yokokawa T, Miura S, Shimizu T, Abe S, Sato T, Suzuki S, Oikawa M, Sakamoto N, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Takeishi Y.

ESC Heart Fail. 2016 Dec;3(4):261-269. Epub 2016 Jul 18.

27.

Associations of dipeptidyl peptidase-4 inhibitors with mortality in hospitalized heart failure patients with diabetes mellitus.

Sato A, Yoshihisa A, Kanno Y, Takiguchi M, Miura S, Shimizu T, Nakamura Y, Yamauchi H, Owada T, Sato T, Suzuki S, Oikawa M, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Takeishi Y.

ESC Heart Fail. 2016 Jun;3(2):77-85. Epub 2015 Nov 30.

28.

Prognostic Impact of Living in Temporary Housing in Fukushima After the Great East Japan Earthquake.

Suzuki S, Yoshihisa A, Kanno Y, Watanabe S, Takiguchi M, Miura S, Yokokawa T, Sato T, Oikawa M, Yamaki T, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Takeishi Y.

J Card Fail. 2017 Jan;23(1):90-92. doi: 10.1016/j.cardfail.2016.10.003. Epub 2016 Oct 18. No abstract available.

PMID:
27769908
29.

Inflammatory involvement in a patient with Leriche syndrome evaluated by 18F-fluorodeoxyglucose PET/MRI.

Masuda A, Yamaki T, Kunii H, Nemoto A, Kubo H, Tominaga H, Oriuchi N, Takenoshita S, Takeishi Y.

J Nucl Cardiol. 2017 Oct;24(5):1819-1821. doi: 10.1007/s12350-016-0680-3. Epub 2016 Sep 20. No abstract available.

PMID:
27650445
30.

Association between levels of anti-angiogenic isoform of vascular endothelial growth factor A and pulmonary hypertension.

Suzuki S, Yoshihisa A, Yokokawa T, Misaka T, Sakamoto N, Sugimoto K, Yamaki T, Kunii H, Nakazato K, Saitoh SI, Takeishi Y.

Int J Cardiol. 2016 Nov 1;222:416-420. doi: 10.1016/j.ijcard.2016.07.277. Epub 2016 Aug 1.

PMID:
27505326
31.

Associations With Eicosapentaenoic Acid to Arachidonic Acid Ratio and Mortality in Hospitalized Heart Failure Patients.

Watanabe S, Yoshihisa A, Kanno Y, Takiguchi M, Yokokawa T, Sato A, Miura S, Shimizu T, Abe S, Sato T, Suzuki S, Oikawa M, Sakamoto N, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Takeishi Y.

J Card Fail. 2016 Dec;22(12):962-969. doi: 10.1016/j.cardfail.2016.04.017. Epub 2016 Apr 29.

32.

Plasma Levels of Receptor for Advanced Glycation End-Products and High-Mobility Group Box 1 in Patients With Pulmonary Hypertension.

Suzuki S, Nakazato K, Sugimoto K, Yoshihisa A, Yamaki T, Kunii H, Suzuki H, Saitoh S, Takeishi Y.

Int Heart J. 2016;57(2):234-40. doi: 10.1536/ihj.15-188. Epub 2016 Mar 11.

33.

Predominance of Abdominal Visceral Adipose Tissue Reflects the Presence of Aortic Valve Calcification.

Oikawa M, Owada T, Yamauchi H, Misaka T, Machii H, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y.

Biomed Res Int. 2016;2016:2174657. doi: 10.1155/2016/2174657. Epub 2016 Jan 24.

34.

The association between circulating anti-angiogenic isoform of vascular endothelial growth factor and clinical profiles in patients with peripheral artery disease.

Sato A, Yoshihisa A, Yokokawa T, Shimizu T, Nakamura Y, Misaka T, Kamioka M, Kaneshiro T, Suzuki S, Kunii H, Saitoh S, Takeishi Y.

Int J Cardiol. 2016 Mar 15;207:368-9. doi: 10.1016/j.ijcard.2016.01.189. Epub 2016 Jan 15. No abstract available.

PMID:
26820370
35.

Vulnerable plaque on the common iliac artery detected by (18)F-FDG PET/MRI.

Masuda A, Yamaki T, Sakamoto N, Kunii H, Ito H, Nanbu T, Kubo H, Hara T, Takenoshita S, Takeishi Y.

Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):793-4. doi: 10.1007/s00259-015-3296-y. Epub 2016 Jan 12. No abstract available.

PMID:
26753601
36.

Relationship of hyperuricemia with mortality in heart failure patients with preserved ejection fraction.

Shimizu T, Yoshihisa A, Kanno Y, Takiguchi M, Sato A, Miura S, Nakamura Y, Yamauchi H, Owada T, Abe S, Sato T, Suzuki S, Oikawa M, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y.

Am J Physiol Heart Circ Physiol. 2015 Oct;309(7):H1123-9. doi: 10.1152/ajpheart.00533.2015. Epub 2015 Aug 21.

37.

Effects of an extended photoperiod on gonadal function and condition of hair coats in Thoroughbred colts and fillies.

Kunii H, Nambo Y, Okano A, Matsui A, Ishimaru M, Asai Y, Sato F, Fujii K, Nagaoka K, Watanabe G, Taya K.

J Equine Sci. 2015;26(2):57-66. doi: 10.1294/jes.26.57. Epub 2015 Jul 2.

38.

STENTING STRATEGY AND FOLLOW-UP RESULTS OF MULTI-CENTER REGISTRY IN FUKUSHIMA CITY FOR LEFT MAIN CORONARY ARTERY DISEASE: BARE METAL STENT VERSUS DRUG-ELUTING STENT.

Nakazato K, Mizukami H, Ohtake H, Sakamoto N, Yamaki T, Yamaguchi O, Kunii H, Ohwada T, Takeishi Y.

Fukushima J Med Sci. 2015;61(1):79-85. doi: 10.5387/fms.2015-5. Epub 2015 Jul 2.

39.

ENDOGENOUS CARBON MONOXIDE CONCENTRATION IN BLOOD ELEVATES IN ACUTE CORONARY SYNDROME OF NONSMOKER POPULATION.

Kobayashi A, Mizukami H, Sakamoto N, Yamaki T, Kunii H, Nakazato K, Takeishi Y.

Fukushima J Med Sci. 2015;61(1):72-8. doi: 10.5387/fms.2015-1. Epub 2015 Jul 2.

40.

Intravascular ultrasound predictors of acute side branch occlusion in coronary artery bifurcation lesions just after single stent crossover.

Sakamoto N, Hoshino Y, Mizukami H, Sugimoto K, Yamaki T, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y.

Catheter Cardiovasc Interv. 2016 Feb 1;87(2):243-50. doi: 10.1002/ccd.26021. Epub 2015 May 22.

PMID:
26011317
41.

Association of Hypocalcemia With Mortality in Hospitalized Patients With Heart Failure and Chronic Kidney Disease.

Miura S, Yoshihisa A, Takiguchi M, Shimizu T, Nakamura Y, Yamauchi H, Iwaya S, Owada T, Miyata M, Abe S, Sato T, Suzuki S, Oikawa M, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y.

J Card Fail. 2015 Aug;21(8):621-7. doi: 10.1016/j.cardfail.2015.04.015. Epub 2015 May 14.

PMID:
25982827
42.

Beneficial Effects of Positive Airway Pressure Therapy for Sleep-Disordered Breathing in Heart Failure Patients With Preserved Left Ventricular Ejection Fraction.

Yoshihisa A, Suzuki S, Yamauchi H, Sato T, Oikawa M, Kobayashi A, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y.

Clin Cardiol. 2015 Jul;38(7):413-21. doi: 10.1002/clc.22412. Epub 2015 May 12.

43.

Vasopressin V2 receptor antagonist tolvaptan is effective in heart failure patients with reduced left ventricular systolic function and low blood pressure.

Suzuki S, Yoshihisa A, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Abe Y, Saito T, Ohwada T, Suzuki H, Saitoh S, Kubota I, Takeishi Y; AVCMA investigators.

Int Heart J. 2015;56(2):213-8. doi: 10.1536/ihj.14-248. Epub 2015 Feb 23.

44.

Impact of peripheral artery disease on prognosis in hospitalized heart failure patients.

Nakamura Y, Kunii H, Yoshihisa A, Takiguchi M, Shimizu T, Yamauchi H, Iwaya S, Owada T, Abe S, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Sugimoto K, Nakazato K, Suzuki H, Saitoh S, Takeishi Y.

Circ J. 2015;79(4):785-93. doi: 10.1253/circj.CJ-14-1280. Epub 2015 Jan 28.

45.

Epicardial adipose tissue reflects the presence of coronary artery disease: comparison with abdominal visceral adipose tissue.

Oikawa M, Owada T, Yamauchi H, Misaka T, Machii H, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y.

Biomed Res Int. 2015;2015:483982. doi: 10.1155/2015/483982. Epub 2015 Jan 27.

46.

Long-term effects and prognosis in acute heart failure treated with tolvaptan: the AVCMA trial.

Suzuki S, Yoshihisa A, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Abe Y, Saito T, Ohwada T, Suzuki H, Saitoh S, Kubota I, Takeishi Y.

Biomed Res Int. 2014;2014:704289. doi: 10.1155/2014/704289. Epub 2014 Nov 10.

47.

Cyclic variation in heart rate score by holter electrocardiogram as screening for sleep-disordered breathing in subjects with heart failure.

Shimizu T, Yoshihisa A, Iwaya S, Abe S, Sato T, Suzuki S, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y.

Respir Care. 2015 Jan;60(1):72-80. doi: 10.4187/respcare.03341. Epub 2014 Nov 4.

48.

Successful endovascular treatment of chronic total occlusion of superficial femoral artery using retrograde approach from deep femoral artery.

Nakamura Y, Komatsu N, Masuda A, Kunii H, Takeda H, Takeishi Y.

Fukushima J Med Sci. 2014;60(1):43-6. Epub 2014 Jul 15.

49.

Impact of sleep-disordered breathing on heart rate turbulence in heart failure patients.

Yoshihisa A, Suzuki S, Takiguchi M, Shimizu T, Abe S, Sato T, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y.

PLoS One. 2014 Jun 26;9(6):e101307. doi: 10.1371/journal.pone.0101307. eCollection 2014.

50.

Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure.

Abe S, Yoshihisa A, Takiguchi M, Shimizu T, Nakamura Y, Yamauchi H, Iwaya S, Owada T, Miyata M, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y.

PLoS One. 2014 Jun 23;9(6):e100618. doi: 10.1371/journal.pone.0100618. eCollection 2014.

Supplemental Content

Support Center